Isabelle Xavier-de-Britto

Ms. Isabelle Xavier-de-Britto

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
NGNatália Gomes-da-Silva
Natália Gomes-da-Silva
IXIsabelle Xavier-de-Britto
Isabelle Xavier-de-Britto
MSMarilia Amavel Gomes Soares
Marilia Amavel Gomes Soares
NYNatalia Yoshihara
Natalia Yoshihara
DİDerya İlem-Özdemir
Derya İlem-Özdemir
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
Background/Objectives: Lipoxins, particularly Lipoxin A4 (LXA4), are endogenous lipid mediators with potent anti-inflammatory and pro-resolving properties, making them promising candidates for the treatment of inflammatory and neurodegenerative disorders. However, their therapeutic application is limited by poor stability and bioavailability. This study aimed to develop and characterize nanomicelles encapsulating LXA4 (nano-lipoxin A4) to improve its pharmacological efficacy against Alzheimer’s disease (AD), a neurodegenerative condition marked by chronic inflammation and beta-amyloid (Aβ) accumulation. Methods: Nano-lipoxin A4 was synthesized using Pluronic F-127 as a carrier and characterized in terms of morphology, physicochemical stability, and in vitro activity against Aβ fibrils. Dissociation of Aβ fibrils was assessed via Thioflavin-T fluorescence assays and transmission electron microscopy. In vivo biodistribution and pharmacokinetic profiles were evaluated using technetium-99m-labeled nano-lipoxin A4 in rodent models. Hepatic biochemical parameters were also measured to assess potential systemic effects. Results: In vitro studies demonstrated that nano-lipoxin A4 effectively dissociated Aβ fibrils at concentrations of 50 nM and 112 nM. Electron microscopy confirmed the disruption of fibrillar structures. In vivo imaging revealed predominant accumulation in the liver and spleen, consistent with reticuloendothelial system uptake. Pharmacokinetic analysis showed a prolonged half-life (63.95 h) and low clearance rate (0.001509 L/h), indicating sustained systemic presence. Biochemical assays revealed elevated liver enzyme levels, suggestive of increased hepatic metabolism or potential hepatotoxicity. Conclusions: Nano-lipoxin A4 exhibits significant therapeutic potential for Alzheimer’s disease through effective modulation of Aβ pathology and favorable pharmacokinetic characteristics. However, the elevation in liver enzymes necessitates further investigation into systemic safety to support clinical translation.

14 October 2024 in Explora: Environment and Resource
Verified
Journal Article
Open access
PDF file
AMAfonso Eduardo Magalhães Muzitano
Afonso Eduardo Magalhães Muzitano
FPFilipe Leal Portilho
Filipe Leal Portilho
IXIsabelle Xavier-de-Britto
Isabelle Xavier-de-Britto
MSMarilia Amavel Gomes Soares
Marilia Amavel Gomes Soares
LALuciana Alencar
Luciana Alencar
RSRalph Santos-Oliveira
Ralph Santos-Oliveira
This study explores the application of graphene quantum dots (GQDs) as innovative nanomaterials for the efficient removal of nuclear materials from metal and plastic surfaces, especially in contexts involving terrorist threats, such as “dirty bombs” and radiological dispersal devices (RDDs). These devices use conventional explosives combined with radioactive materials to contaminate large areas, posing significant risks to health and the environment. This investigation addresses the growing global concern about the use and threat of such weapons, particularly in the context of escalating wars and the increasing vulnerability of nuclear facilities to security breaches. Our focus is on the unique properties of GQDs—such as their chemical stability, high surface area, quantum confinement effects, and electronic characteristics—that enhance their ability to effectively adsorb radioactive isotopes. We examine the potential of GQDs to interact with various radioactive materials, focusing on isotopes commonly associated with RDDs, such as cesium-137, cobalt-60, strontium-90, and iridium-192. Functionalization techniques are employed to enhance the interaction of GQDs with specific isotopes, thus improving the decontamination process. Our findings reveal that GQDs can efficiently remove iodine-131 (I-131) from several metals: Aluminum (91.27%), zinc (98.67%), and monel (96.40%). They also demonstrate high efficiency in removing I-131 from rigid polyvinyl chloride. On the other hand, GQDs presented moderate efficiency in removing technetium-99m, with removal rates of 64.93% from monel, 55.11% from aluminum, and 41.80% from zinc. Overall, GQDs could play a crucial role in mitigating the consequences of dirty bomb detonations, offering a quick and effective method to reduce radiological impacts in affected areas. This research enhances our understanding of nanomaterials in responding to radiological emergencies, presenting GQDs as a viable solution to contemporary challenges in public health and safety. The implications of this study extend beyond immediate decontamination, suggesting broader applications of GQDs in environmental safety and nuclear safety protocols.